07:14 AM EDT, 05/07/2026 (MT Newswires) -- Insmed ( INSM ) reported a Q1 loss Thursday of $0.76 per share, narrowing from a loss of $1.42 a year earlier.

Analysts surveyed by FactSet expected a loss of $0.96.

Revenue for the quarter ended March 31 was $306.0 million, up from $92.8 million a year earlier.

Analysts surveyed by FactSet expected $300.8 million.

For 2026, Insmed ( INSM ) reiterated its Brinsupri revenue guidance of at least $1 billion and Arikayce revenue guidance of $450 million to $470 million.

Insmed ( INSM ) shares were 11% lower in premarket activity.